secwatch / observer

8-K filed February 26, 2025, 6:59 PM ET ticker VIR CIK 0001706431

earnings confidence high sentiment neutral materiality 0.60

Vir Biotechnology reports Q4 and full year 2024 financial results and pipeline updates

Vir Biotechnology, Inc.

2024-FY EPS reported -$3.83 revenue$74,205,000

Cash, cash equivalents and investments of $1.10 billion as of Dec 31, 2024, providing cash runway into mid-2027.
Net loss for Q4 2024 was $104.6 million ($0.76 per share) vs $116.0 million ($0.86 per share) in Q4 2023.
Phase 3 ECLIPSE registrational program in chronic hepatitis delta on track for first patient in first half of 2025.
Initial Phase 1 data for VIR-5818 showed tumor shrinkage in 50% (10/20) of participants at doses ≥400 µg/kg.
Company plans to initiate Phase 1 study of VIR-5525, dual-masked EGFR-targeting T-cell engager, in first half 2025.

item 2.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001628280-25-008163
form_type: 8-K
ticker: VIR
cik: 0001706431
company_name: Vir Biotechnology, Inc.
filed_at: 2025-02-26T23:59:59+00:00
discovered_at: 2026-05-14T18:03:04.517325+00:00
generated_at: 2026-05-26T03:41:45.642916+00:00
sec_items: ["2.02", "9.01"]
event_type: earnings
sentiment: neutral
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001628280-25-008163
json_url: https://secwatch.observer/filing/0001628280-25-008163.json
markdown_url: https://secwatch.observer/filing/0001628280-25-008163.md
text_url: https://secwatch.observer/filing/0001628280-25-008163.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1706431/000162828025008163/0001628280-25-008163-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1706431/000162828025008163/vir-20250226.htm
generated_by_model: deepseek-v4-flash:cloud
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

DAVEY TREE EXPERT CO

Davey Tree Q1 net loss widens to $10.7M; revenue flat at $435.8M

DAVEY TREE EXPERT CO June 1, 2026, 1:50 PM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

BKE

Buckle Q1 net income $46.9M ($0.93/share), sales up 6.1% to $288.7M

BUCKLE INC May 29, 2026, 3:38 PM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

HIND

Vyome Q1 net loss $963K, cash $8.8M, inks JAK inhibitor licensing deal with Impetis

Vyome Holdings, Inc May 29, 2026, 8:42 AM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

PKE

Park Aerospace Q4 sales up 43% to $24.2M; EPS $0.19 vs $0.06 YoY; full-year net earnings double to $11.3M

PARK AEROSPACE CORP May 28, 2026, 4:29 PM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

GAP

Gap Inc. Q1 net sales up 1% to $3.5B; adj. EPS $0.38; raises full-year EPS outlook

GAP INC May 28, 2026, 4:16 PM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

PagerDuty Q1 revenue $121M up 1% YoY; new CEO DiLullo; $100M buyback

PagerDuty, Inc. May 28, 2026, 4:07 PM ET earnings Items 2.02, 8.01, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

RICK

RCI Hospitality posts Q2 GAAP loss of $0.04 on $7.6M impairment; non-GAAP EPS rises to $0.78

RCI HOSPITALITY HOLDINGS, INC. May 28, 2026, 4:07 PM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

NTAP

NetApp reports Q4/FY2026 results (details not in filing) and adds $1B buyback

NetApp, Inc. May 28, 2026, 4:05 PM ET earnings Items 2.02, 8.01, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001628280-25-008163

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.